(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

INTERTEK PHARMACEUTICAL SERVICES

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

INTERTEK PHARMACEUTICAL SERVICES

ST13

US500000085724581

Class

35, 42, 44

Filing

85724581

Registration

4647353

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

47

Latest update

06/29/2024

Trademark type

Word

Nice classes

35, 42, 44

Filing date

09/10/2012

Registration date

12/02/2014

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/29/2024

Last transaction

06/29/2024

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

05/15/2012

First use in commerce

05/15/2012

Drawing code

4

Owner type

03

Owner location

Houston, TX, US

Examiner

KOZAK, EVIN L

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Intertek USA, Inc.

Representatives

B. Brett Heavner Finnegan, Henderson, Farabow, Garrett & Dunner LL

Technical classification

Nice Classes

Class 35Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Business consulting services in the fields of pharmaceuticals and medical devices

Class 42

Testing and inspecting all types of goods and materials in the fields of pharmaceuticals and medical devices and making related engineering analyses and reports; providing quality assurance services in the fields of pharmaceuticals and medical devices; testinginspectionresearch of pharmaceuticals; product research and development; pharmaceutical research and development; testinganalysis and evaluation of the goods and services of others for the purpose of certification; product design and development consulting in the field of medical devices

Class 44

Technical consulting services in the field of pharmaceuticals

Publications

History of USPTO decisions and trademark events.

47 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

06/29/2024

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

06/29/2024

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

06/29/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/29/2024

E89R

TEAS SECTION 8 & 9 RECEIVED

04/01/2024

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

12/02/2023

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

03/08/2021

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

03/08/2021

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/08/2021

E815

TEAS SECTION 8 & 15 RECEIVED

12/02/2020

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

12/02/2019

R.PR

REGISTERED-PRINCIPAL REGISTER

12/02/2014

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/16/2014

PUBO

PUBLISHED FOR OPPOSITION

09/16/2014

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/27/2014

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

08/13/2014

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/12/2014

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/05/2014

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/05/2014

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

08/04/2014

EXPI

EX PARTE APPEAL-INSTITUTED

08/04/2014

JURT

JURISDICTION RESTORED TO EXAMINING ATTORNEY

08/04/2014

EXAF

EXPARTE APPEAL RECEIVED AT TTAB

08/04/2014

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

02/03/2014

GNFR

FINAL REFUSAL E-MAILED

02/03/2014

CNFR

FINAL REFUSAL WRITTEN

02/03/2014

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/28/2014

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/28/2014

ALIE

ASSIGNED TO LIE

01/21/2014

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/02/2014

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

07/15/2013

GNRT

NON-FINAL ACTION E-MAILED

07/15/2013

CNRT

NON-FINAL ACTION WRITTEN

07/15/2013

XAEC

EXAMINER'S AMENDMENT ENTERED

07/11/2013

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

07/11/2013

GNEA

EXAMINERS AMENDMENT E-MAILED

07/11/2013

CNEA

EXAMINERS AMENDMENT -WRITTEN

07/11/2013

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/10/2013

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/09/2013

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/09/2013

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

01/09/2013

GNRT

NON-FINAL ACTION E-MAILED

01/09/2013

CNRT

NON-FINAL ACTION WRITTEN

01/09/2013

DOCK

ASSIGNED TO EXAMINER

01/04/2013

MPMK

NOTICE OF PSEUDO MARK MAILED

09/15/2012

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/14/2012

NWAP

NEW APPLICATION ENTERED

09/13/2012

Continuous trademark protection

Get notified about every new filing that threatens INTERTEK PHARMACEUTICAL SERVICES or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.